Həyat‑pro CEO‑su proqnozlaşdırır ki, Trampın FDA namizədi abort dərmanı risklərinə yenidən diqqət yetirə bilər
foxnews.com
25.08.2026 19:38
11 baxış
Trump's FDA nominee Heidi Overton could bring renewed scrutiny to mifepristone, says Americans United for Life CEO who calls her a "pro-life" pick.
Əlaqəli xəbərlər
Texans: New OL Injury Could be Bad News for CJ Stroud
newsweek.com · 26.08
Meet Dean Roy, the 15-Year-Old Running for Vermont Governor and Ready for ‘Impact’
nytimes.com · 26.08
Trump Says Mojtaba Khamenei Is Alive. Either Way, His Ghost Rules Iran
newsweek.com · 26.08
Map Shows Where New Home Sales Falling as Prices Hit Lowest Level Since 2021
newsweek.com · 26.08
Kyiv Reveals 'Drone Aircraft Carrier' to Menace Russian Black Sea Fleet
newsweek.com · 26.08
Tua Tagovailoa Facing Harsh Reality With Atlanta Falcons
newsweek.com · 26.08